JP2006321725A - Emulsion-form skin preparation for external use - Google Patents
Emulsion-form skin preparation for external use Download PDFInfo
- Publication number
- JP2006321725A JP2006321725A JP2005144068A JP2005144068A JP2006321725A JP 2006321725 A JP2006321725 A JP 2006321725A JP 2005144068 A JP2005144068 A JP 2005144068A JP 2005144068 A JP2005144068 A JP 2005144068A JP 2006321725 A JP2006321725 A JP 2006321725A
- Authority
- JP
- Japan
- Prior art keywords
- mass
- skin
- external preparation
- salt
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 58
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 67
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 48
- 235000011187 glycerol Nutrition 0.000 claims abstract description 35
- 239000002734 clay mineral Substances 0.000 claims abstract description 31
- 150000003839 salts Chemical class 0.000 claims abstract description 22
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 14
- 239000000783 alginic acid Substances 0.000 claims abstract description 14
- 229920000615 alginic acid Polymers 0.000 claims abstract description 14
- 229960001126 alginic acid Drugs 0.000 claims abstract description 14
- 150000004781 alginic acids Chemical class 0.000 claims abstract description 14
- -1 dimethyl distearyl ammonium chloride modified montmorillonite Chemical class 0.000 claims description 48
- 239000003995 emulsifying agent Substances 0.000 claims description 25
- 239000003860 topical agent Substances 0.000 claims 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical class O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 abstract description 7
- 229910052901 montmorillonite Inorganic materials 0.000 abstract description 5
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical group [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 abstract description 4
- 229960005150 glycerol Drugs 0.000 description 31
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 26
- 239000002537 cosmetic Substances 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 15
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 15
- 229960005323 phenoxyethanol Drugs 0.000 description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 13
- 229940032094 squalane Drugs 0.000 description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 150000005846 sugar alcohols Polymers 0.000 description 12
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000004166 Lanolin Substances 0.000 description 10
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 229940039717 lanolin Drugs 0.000 description 10
- 235000019388 lanolin Nutrition 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 229960002703 undecylenic acid Drugs 0.000 description 10
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 9
- 239000003093 cationic surfactant Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 229920001187 thermosetting polymer Polymers 0.000 description 8
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 7
- 235000021355 Stearic acid Nutrition 0.000 description 7
- 239000006096 absorbing agent Substances 0.000 description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 239000008117 stearic acid Substances 0.000 description 7
- 229960004274 stearic acid Drugs 0.000 description 7
- QIZPVNNYFKFJAD-UHFFFAOYSA-N 1-chloro-2-prop-1-ynylbenzene Chemical compound CC#CC1=CC=CC=C1Cl QIZPVNNYFKFJAD-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 229940086555 cyclomethicone Drugs 0.000 description 6
- 238000004945 emulsification Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 229940035023 sucrose monostearate Drugs 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 4
- 229910000275 saponite Inorganic materials 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000008365 aqueous carrier Substances 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical class CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical class CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical group CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- REVKSDVMARYEDI-UHFFFAOYSA-N 2-[di(docosyl)amino]ethane-1,1-diol Chemical class CCCCCCCCCCCCCCCCCCCCCCN(CC(O)O)CCCCCCCCCCCCCCCCCCCCCC REVKSDVMARYEDI-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 244000188595 Brassica sinapistrum Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- CLCWHUQIEVRTLD-UHFFFAOYSA-N CC(C)CCCCCCCCCCCCCNCC1=CC=CC=C1 Chemical class CC(C)CCCCCCCCCCCCCNCC1=CC=CC=C1 CLCWHUQIEVRTLD-UHFFFAOYSA-N 0.000 description 1
- FDZFJNDFLZUPBG-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCCCCNCCC1=CC=CC=C1 Chemical class CCCCCCCCCCCCCCCCCCCCNCCC1=CC=CC=C1 FDZFJNDFLZUPBG-UHFFFAOYSA-N 0.000 description 1
- DQWHIEQZLUWRDT-UHFFFAOYSA-N CCCCCCCCCCCCCCCCN(CC)CCC1=CC=CC=C1 Chemical class CCCCCCCCCCCCCCCCN(CC)CCC1=CC=CC=C1 DQWHIEQZLUWRDT-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical class NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- INPYEZXVCLMZQS-UHFFFAOYSA-N N-benzyl-18-methylnonadecan-1-amine Chemical class CC(C)CCCCCCCCCCCCCCCCCNCC1=CC=CC=C1 INPYEZXVCLMZQS-UHFFFAOYSA-N 0.000 description 1
- WPALZCNDTILJMY-UHFFFAOYSA-N N-benzyl-22-methyltricosan-1-amine Chemical class CC(C)CCCCCCCCCCCCCCCCCCCCCNCC1=CC=CC=C1 WPALZCNDTILJMY-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229930194270 alpha-Vitamin Natural products 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- QDYLMAYUEZBUFO-UHFFFAOYSA-N cetalkonium chloride Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 QDYLMAYUEZBUFO-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- DGWLPHZXWGOQMS-UHFFFAOYSA-N diethyl-methyl-octadecylazanium Chemical class CCCCCCCCCCCCCCCCCC[N+](C)(CC)CC DGWLPHZXWGOQMS-UHFFFAOYSA-N 0.000 description 1
- YCFMVCGMSIYPOE-UHFFFAOYSA-N diethyl-methyl-tetradecylazanium Chemical class CCCCCCCCCCCCCC[N+](C)(CC)CC YCFMVCGMSIYPOE-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- UCYFZDNMZYZSPN-UHFFFAOYSA-N docosyl(trimethyl)azanium Chemical class CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C UCYFZDNMZYZSPN-UHFFFAOYSA-N 0.000 description 1
- LTUVKKLDUNUINC-UHFFFAOYSA-N docosyl-ethyl-dimethylazanium Chemical class CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)CC LTUVKKLDUNUINC-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- VICYBMUVWHJEFT-UHFFFAOYSA-N dodecyltrimethylammonium ion Chemical class CCCCCCCCCCCC[N+](C)(C)C VICYBMUVWHJEFT-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- WUUOYCPDGWDPRO-UHFFFAOYSA-N ethyl-dimethyl-octadecylazanium Chemical class CCCCCCCCCCCCCCCCCC[N+](C)(C)CC WUUOYCPDGWDPRO-UHFFFAOYSA-N 0.000 description 1
- DELLBLKQOILBPT-UHFFFAOYSA-N ethyl-dimethyl-tetradecylazanium Chemical class CCCCCCCCCCCCCC[N+](C)(C)CC DELLBLKQOILBPT-UHFFFAOYSA-N 0.000 description 1
- VCAVAURZPNANDQ-UHFFFAOYSA-N ethyl-hexadecyl-dimethylazanium Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)CC VCAVAURZPNANDQ-UHFFFAOYSA-N 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940095050 propylene Drugs 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- GLFDLEXFOHUASB-UHFFFAOYSA-N trimethyl(tetradecyl)azanium Chemical class CCCCCCCCCCCCCC[N+](C)(C)C GLFDLEXFOHUASB-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚外用剤に関し、更に詳細には、乳化剤形の皮膚外用剤に好適な皮膚外用剤に関する。 The present invention relates to a skin external preparation, and more particularly to a skin external preparation suitable for an emulsifier-type skin external preparation.
乳化剤形の皮膚外用剤に於いて、グリセリンのような、保湿性の高い多価アルコールを高濃度に含有せしめることは、乳化形態で含有される油脂分による閉塞作用と、前記多価アルコールによる角層の保湿作用の両方が得られることから、機能的には非常に好ましいことと言える。特に、油中水乳化剤形や、油中水中油乳化剤形などの最外相が油相である乳化剤形に於いては前記閉塞効果はより顕著であり、保湿性多価アルコールの含有はより好ましいものと言える。しかしながら、多価アルコールの含有量を増加せしめることは、乳化系の不安定化要因となり易く、安定性の確保が困難になる傾向にあった。この様な形態で安定性を確保するためには、高級アルコールなどによって界面の強度を向上させることが考えられるが、この様な技術では皮膚外用剤の延展時の摩擦係数も著しく増加せしめてしまい、使用性を著しく損なう場合が存した。 In the emulsifier-type external preparation for skin, the inclusion of a highly concentrated polyhydric alcohol such as glycerin at a high concentration is due to the obstructive action caused by the oil and fat contained in the emulsified form and the angle caused by the polyhydric alcohol. Since both the moisturizing action of the layer can be obtained, it can be said that it is very functionally preferable. In particular, in the emulsifier form in which the outermost phase is an oil phase, such as a water-in-oil emulsifier form or an oil-in-water oil-in-water emulsifier form, the above-mentioned blocking effect is more remarkable, and the inclusion of a moisturizing polyhydric alcohol is more preferable. It can be said. However, increasing the content of the polyhydric alcohol tends to be a destabilizing factor of the emulsification system and tends to make it difficult to ensure stability. In order to ensure stability in such a form, it is conceivable to improve the strength of the interface with higher alcohols, etc., but such a technique also significantly increases the friction coefficient when spreading the external preparation for skin. In some cases, the usability was significantly impaired.
一方、この様な使用性の向上は、保湿性多価アルコールの高濃度含有時の問題にとどまらず、油中水乳化剤形や、油中水中油乳化剤形などの最外相が油相の乳化剤形では、延展時の摩擦係数を低下させ、使用性を高めることが大きな課題となり、高級アルコールに替わる界面の安定剤として、有機変性粘土鉱物が見出されている。(例えば、特許文献1、特許文献2、特許文献3、特許文献4、特許文献5を参照)しかしながら、この様な系では多価アルコールを含有する水相と有機変性粘土鉱物のゲルを形成させる必要が存するが、多価アルコール量が多すぎるとゲルを生成せず、乳化が出来なくなる場合が存し、全含水量に対して0.6〜1.5倍質量のグリセリンとを含有する様な乳化系では有機変性粘土鉱物を用いた乳化は試行されていないのが現状であった。 On the other hand, such improvement in usability is not limited to the problem when containing a high concentration of moisturizing polyhydric alcohol, and the outermost phase such as the water-in-oil emulsifier form or the oil-in-water oil-in-water emulsifier form is the oil phase emulsifier form. Therefore, reducing the coefficient of friction at the time of spreading and improving the usability is a major issue, and organically modified clay minerals have been found as an interfacial stabilizer to replace higher alcohols. (For example, see Patent Document 1, Patent Document 2, Patent Document 3, Patent Document 4, and Patent Document 5) However, in such a system, an aqueous phase containing polyhydric alcohol and an organically modified clay mineral gel are formed. There is a need, but if the amount of polyhydric alcohol is too large, gel may not be formed and emulsification may not be possible, and it contains 0.6 to 1.5 times the mass of glycerin with respect to the total water content. In the current emulsification system, emulsification using an organically modified clay mineral has not been attempted.
他方、1)アルギン酸及び/又はその塩と、2)有機変性粘土鉱物と、3)全含水量に対して0.5〜1.5倍質量のグリセリンとを含有することを構成とする、乳化剤形の皮膚外用剤は全く知られていないし、この様な構成で安定な乳化系が得られることも全く知られていない。 On the other hand, an emulsifier comprising 1) alginic acid and / or a salt thereof, 2) an organically modified clay mineral, and 3) glycerin having a mass of 0.5 to 1.5 times the total water content. No form of external preparation for skin is known, nor is it known that a stable emulsification system can be obtained with such a constitution.
本発明は、この様な状況下為されたものであり、有機変性粘土鉱物を含有する乳化剤形の皮膚外用剤において、使用性と安定性に優れる皮膚外用剤を提供することを課題とする。 The present invention has been made under such circumstances, and an object of the present invention is to provide a skin external preparation excellent in usability and stability in an emulsifier type skin external preparation containing an organically modified clay mineral.
本発明者らは、この様な状況下、有機変性粘土鉱物を含有する乳化剤形の皮膚外用剤において、使用性と安定性に優れる皮膚外用剤を求めて鋭意研究努力を重ねた結果、1)アルギン酸及び/又はその塩と、2)有機変性粘土鉱物と、3)全含水量に対して0.6〜1.5倍質量のグリセリンとを含有することを構成とする、乳化剤形の皮膚外用剤がその様な特性を備えていることを見出し、発明を完成させるに至った。即ち、本発明は以下に示すとおりである。
(1)1)アルギン酸及び/又はその塩と、2)有機変性粘土鉱物と、3)全含水量に対して0.5〜1.5倍質量のグリセリンとを含有することを特徴とする乳化剤形の皮膚外用剤。
(2)前記アルギン酸及び/又はその塩の含有量が0.01〜0.5質量%であることを特徴とする、(1)に記載の皮膚外用剤。
(3)有機変性粘土鉱物が、ジメチルジステアリルアンモニウムクロリド変性モンモリロナイトであることを特徴とする、(1)又は(2)に記載の皮膚外用剤。
(4)前記グリセリンの含有量が、10〜25質量%であることを特徴とする、(1)〜(3)何れか1項に記載の皮膚外用剤。
(5)前記乳化剤形が、多相乳化剤形であることを特徴とする、(1)〜(4)何れか1項に記載の皮膚外用剤。
(6)前記多相乳化剤形が、油中水中油乳化剤形であることを特徴とする、(5)に記載の皮膚外用剤。
Under these circumstances, the present inventors have made extensive research efforts to find a skin external preparation having excellent usability and stability in an emulsifier-type skin external preparation containing an organically modified clay mineral. An external emulsifier type skin comprising alginic acid and / or a salt thereof, 2) an organically modified clay mineral, and 3) glycerin having a mass of 0.6 to 1.5 times the total water content. The inventors have found that the agent has such characteristics, and have completed the invention. That is, the present invention is as follows.
(1) An emulsifier comprising 1) alginic acid and / or a salt thereof, 2) an organically modified clay mineral, and 3) glycerin having a mass of 0.5 to 1.5 times the total water content. Topical skin preparation.
(2) The external preparation for skin according to (1), wherein the content of the alginic acid and / or salt thereof is 0.01 to 0.5% by mass.
(3) The skin external preparation according to (1) or (2), wherein the organically modified clay mineral is dimethyl distearyl ammonium chloride modified montmorillonite.
(4) The skin external preparation according to any one of (1) to (3), wherein a content of the glycerin is 10 to 25% by mass.
(5) The external preparation for skin according to any one of (1) to (4), wherein the emulsifier form is a multiphase emulsifier form.
(6) The skin external preparation according to (5), wherein the multiphase emulsifier form is an oil-in-water oil-in-water emulsifier form.
本発明によれば、有機変性粘土鉱物を含有する乳化剤形の皮膚外用剤において、使用性と安定性に優れる皮膚外用剤を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, in the emulsifier type skin external preparation containing an organic modified clay mineral, the skin external preparation excellent in usability and stability can be provided.
(1)本発明の皮膚外用剤の必須成分であるアルギン酸
本発明の皮膚外用剤は、乳化剤形であって、アルギン酸及び/又はその塩を含有することを特徴とする。アルギン酸及び/又はその塩は、化粧料などの皮膚外用剤、食品などの分野で水溶性の増粘成分として広く使用されている。これらには、増粘の程度によって幾つかのグレードが存する。超低粘度品、高純度品、高粘度品などのグレードが例示できる。その塩としては、通常知られているものであれば、特段の限定無く適用することが出来、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩、カルシウム、マグネシウム等のアルカリ土類金属塩、アンモニウム塩、トリエタノールアミン塩、トリエチルアミン塩等の有機アミン塩類、リジン塩、アルギニン塩等の塩基性アミノ酸塩等が好ましく例示できる。超低粘度品などでは1質量%における粘度は、100〜200cp程度であり、高純度品では300〜700cp程度であり、高粘度品では900〜1200cp程度であると言われている。この粘度範囲であれば、本発明の皮膚外用剤に於いては特段の限定無く使用することが出来る。本発明の皮膚外用剤では、1質量%の水溶液の1気圧20℃の粘度が10〜1500cpのものであれば、特段の限定無く許容できると言える。好ましい粘度は、この条件下で200〜1000cpのものである。本発明の皮膚外用剤に於いては、かかるアルギン酸及び/又はその塩は唯一種を含有せしめることも出来るし、二種以上を組み合わせて含有せしめることも出来る。本発明の皮膚外用剤に於ける、かかるアルギン酸及び/又はその塩の好ましい含有量は、総量で、皮膚外用剤全量に対して、0.01〜1質量%であり、より好ましくは、0.05〜0.5質量%である。本発明の皮膚外用剤に於いて、かかるアルギン酸及び/又はその塩は、グリセリンなどの多価アルコールの含有量が多い形態でも、有機変性粘土鉱物の乳化能を維持せしめる作用を有する。前記の含有量より低い場合は、この様な作用を発現しない場合が存し、多すぎる場合には粘度が高くなりすぎて使用性を損なう場合が存する。
(1) Alginic acid as an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention is in an emulsifier form and contains alginic acid and / or a salt thereof. Alginic acid and / or a salt thereof is widely used as a water-soluble thickening component in the fields of skin external preparations such as cosmetics and foods. There are several grades of these depending on the degree of thickening. Examples include ultra-low viscosity products, high-purity products, and high-viscosity products. As the salt, if it is usually known, it can be applied without particular limitation, for example, alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as calcium and magnesium, ammonium, etc. Preferred examples include organic amine salts such as salts, triethanolamine salts and triethylamine salts, and basic amino acid salts such as lysine salts and arginine salts. It is said that the viscosity at 1% by mass is about 100 to 200 cp for an ultra low viscosity product, about 300 to 700 cp for a high purity product, and about 900 to 1200 cp for a high viscosity product. Within this viscosity range, the skin external preparation of the present invention can be used without any particular limitation. In the external preparation for skin of the present invention, it can be said that it is acceptable without particular limitation as long as the viscosity at 1 atm and 20 ° C. of a 1% by mass aqueous solution is 10 to 1500 cp. Preferred viscosities are between 200 and 1000 cp under these conditions. In the external preparation for skin of the present invention, such alginic acid and / or a salt thereof may contain only one species or a combination of two or more species. The preferable content of alginic acid and / or a salt thereof in the external preparation for skin of the present invention is 0.01 to 1% by mass relative to the total amount of the external preparation for skin, and more preferably 0.8%. It is 05-0.5 mass%. In the external preparation for skin of the present invention, such alginic acid and / or a salt thereof has an action of maintaining the emulsifying ability of the organically modified clay mineral even in a form having a high content of polyhydric alcohol such as glycerin. When the content is lower than the above-mentioned content, there is a case where such an effect is not exhibited, and when it is too much, there is a case where the viscosity becomes too high and the usability is impaired.
(2)本発明の皮膚外用剤の必須成分である有機変性粘土鉱物
本発明の皮膚外用剤は、乳化剤形であって、有機変性粘土鉱物を含有することを特徴とする。有機変性粘土鉱物の基体となる粘土鉱物は、天然に存在したり、天然物を加工して得られる、層間に金属原子乃至はイオンを保持する、多層構造のコロイド性含水ケイ酸アルミニウムの総称を意味し、前記金属原子乃至イオンとしては、Al、Fe(III)、Mn(III)、Cr(III)、Mg、Fe(II)、Ni、Zn、Li、Mn(II)、K、Na、1/2Caまたは1/2Mg等が好適に例示できる。具体的な鉱物の名称とすれば、モンモリロナイト、サポナイト、ヘクトライト等が好ましく例示できる。かかる粘土鉱物を4級アミノ基と、炭素数10〜30の長鎖アルキル基とを有する界面活性剤、好ましくはカチオン性界面活性剤で処理し、該粘土鉱物の表面に界面活性剤の炭化水素基が存するように処理することにより、必須成分である有機変性粘土鉱物は得られる。かかる処理に好ましく用いる、前記カチオン性界面活性剤を具体的に例示すれば、ドデシルトリメチルアンモニウムの塩、ミリスチルトリメチルアンモニウムの塩、セチルトリメチルアンモニウムの塩、ステアリルトリメチルアンモニウムの塩、アルキルトリメチルアンモニウムの塩、ベヘニルトリメチルアンモニウムの塩、ミリスチルジメチルエチルアンモニウムの塩、セチルジメチルエチルアンモニウムの塩、ステアリルジメチルエチルアンモニウムの塩、アルキルジメチルエチルアンモニウムの塩、ベヘニルジメチルエチルアンモニウムの塩、ミリスチルジエチルメチルアンモニウムの塩、セチルジエチルメチルアンモニウムの塩、ステアリルジエチルメチルアンモニウムの塩、アルキルジエチルメチルアンモニウムの塩、ベヘニルジエチルメチルアンモニウムの塩、ベンジルジメチルミリスチルアンモニウムの塩、ベンジルジメチルセチルアンモニウムの塩、ベンジルジメチルステアリルアンモニウムの塩、ベンジルジメチルベヘニルアンモニウムの塩、ベンジルメチルエチルセチルアンモニウムの塩、ベンジルメチルエチルステアリルアンモニウムの塩、ジメチルジステアリルアンモニウムの塩、ジベヘニルジヒドロキシエチルアンモニウムの塩等が好ましく例示でき、前記塩としては、クロリド、ブロミド、硫酸塩などの鉱酸塩が好ましく例示でき、中でもクロリドが特に好ましい。特に好ましいカチオン性界面活性剤は、長鎖のアルキル基が1個の窒素原子に2個ついた形の、所謂「2鎖型」のカチオン性界面活性剤であり、ジメチルジステアリルアンモニウムの塩が特に好ましく例示でき、塩としてはクロリドが好ましく例示できる。前記の処理は、前記粘土鉱物の表面上に均一に前記カチオン性界面活性剤を固着せしめることが出来れば特に手段を問わないが、例えば、水性担体に基体たる粘土鉱物を分散せしめ、これにカチオン性界面活性剤の水性担体溶液を加え、しかる後に水性担体を減圧濃縮などの手段により除去すること等が好適に例示できる。この時の粘土鉱物とカチオン性界面活性剤の質量比は、99:1〜70:30が好ましく、95:5〜80:20が特に好ましい。前記カチオン性界面活性剤に変えて、非イオン性界面活性剤、両性界面活性剤、アニオン性界面活性剤を用いて有機基を導入することも出来、この様なものも本発明の皮膚外用剤の必須成分を構成するが、特に好ましいものは、カチオン性界面活性剤を用いて有機変性したものである。この様な有機変性粘土鉱物には、既に市販されているものが存し、かかる市販品を購入して利用することも出来る。好ましい市販品としては、ベントン38(ジメチルジステアリルアンモニウムクロライド処理モンモリナイト:ナショナルレッド社製)等が好適に例示できる。本発明の皮膚外用剤には、この様な有機変性粘土鉱物は唯一種を含有することも出来るし、二種以上を組み合わせて含有せしめることも出来る。本発明の皮膚外用剤に於ける、かかる有機変性粘土鉱物の好ましい含有量は、総量で0.1〜5質量%であり、より好ましくは0.5〜3質量%である。かかる有機変性粘土鉱物の含有量が少なすぎると、乳化が不良になる場合が存し、含有量が多すぎるとゲル強度が著しくなり、使用性を損なう場合が存する。
(2) Organically modified clay mineral that is an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention is an emulsifier type and contains an organically modified clay mineral. Clay mineral, which is the base of organically modified clay minerals, is a generic name for colloidal hydrous aluminum silicate with a multi-layer structure that exists in nature or is obtained by processing natural products and retains metal atoms or ions between layers. The metal atoms or ions include Al, Fe (III), Mn (III), Cr (III), Mg, Fe (II), Ni, Zn, Li, Mn (II), K, Na, 1 / 2Ca or 1 / 2Mg can be preferably exemplified. Specific examples of mineral names include montmorillonite, saponite, and hectorite. The clay mineral is treated with a surfactant having a quaternary amino group and a long-chain alkyl group having 10 to 30 carbon atoms, preferably a cationic surfactant, and the surface of the clay mineral has a hydrocarbon as a surfactant. By processing so that a group exists, an organically modified clay mineral which is an essential component can be obtained. Specific examples of the cationic surfactant preferably used for such treatment include dodecyltrimethylammonium salt, myristyltrimethylammonium salt, cetyltrimethylammonium salt, stearyltrimethylammonium salt, alkyltrimethylammonium salt, Behenyltrimethylammonium salt, myristyldimethylethylammonium salt, cetyldimethylethylammonium salt, stearyldimethylethylammonium salt, alkyldimethylethylammonium salt, behenyldimethylethylammonium salt, myristyldiethylmethylammonium salt, cetyldiethyl Methyl ammonium salt, stearyl diethyl methyl ammonium salt, alkyl diethyl methyl ammonium salt, behenyl di Tilmethylammonium salt, benzyldimethylmyristylammonium salt, benzyldimethylcetylammonium salt, benzyldimethylstearylammonium salt, benzyldimethylbehenylammonium salt, benzylmethylethylcetylammonium salt, benzylmethylethylstearylammonium salt, Preferred examples include salts of dimethyl distearyl ammonium, dibehenyl dihydroxyethyl ammonium, and the like. Preferred examples of the salt include mineral salts such as chloride, bromide, and sulfate, with chloride being particularly preferred. A particularly preferred cationic surfactant is a so-called “two-chain type” cationic surfactant in which two long-chain alkyl groups are attached to one nitrogen atom, and a salt of dimethyl distearyl ammonium is used. Particularly preferable examples are exemplified, and as the salt, chloride is preferably exemplified. The treatment is not particularly limited as long as the cationic surfactant can be uniformly fixed on the surface of the clay mineral. For example, the clay mineral as a base is dispersed in an aqueous carrier, and the cationic mineral is dispersed therein. It is preferable to add an aqueous carrier solution of a surfactant and then remove the aqueous carrier by means such as concentration under reduced pressure. The mass ratio of the clay mineral and the cationic surfactant at this time is preferably 99: 1 to 70:30, and particularly preferably 95: 5 to 80:20. In place of the cationic surfactant, an organic group can be introduced using a nonionic surfactant, an amphoteric surfactant, or an anionic surfactant. Of these, essential components are particularly preferred, but organically modified with a cationic surfactant. Such organically modified clay minerals already exist on the market, and such commercial products can be purchased and used. Preferable examples of commercially available products include Benton 38 (dimethyl distearyl ammonium chloride-treated montmorillonite: National Red). In the external preparation for skin of the present invention, such an organically modified clay mineral can contain only one species or a combination of two or more species. The preferable content of the organically modified clay mineral in the external preparation for skin of the present invention is 0.1 to 5% by mass in total, and more preferably 0.5 to 3% by mass. If the content of the organically modified clay mineral is too small, emulsification may be poor, and if the content is too large, the gel strength may be remarkable and the usability may be impaired.
(3)本発明の皮膚外用剤に於けるグリセリンの含有
本発明の皮膚外用剤は、乳化剤形であって、全含水量に対して0.5〜1.5倍質量、より好ましくは。0.6〜1.2倍量のグリセリンとを含有することを特徴とする。前記の如くに、多相乳化剤形の閉塞性と、多価アルコールの保湿性(水分保持性)とを備え、使用性を向上せしめるためには、多価アルコールの含有量を水相の限度まで高めることが好ましい。これが前記の値である。この様な形態を取ることにより、使用性を損なわずに、閉塞性に優れる多相乳化剤形に於いて、多価アルコールによる保湿性を付加することが出来る。グリセリンの皮膚外用剤に於ける含有量は15〜35質量%が好ましく、17〜25質量%がより好ましい。
(3) Inclusion of glycerin in the external preparation for skin of the present invention The external preparation for skin of the present invention is in an emulsifier form, more preferably 0.5 to 1.5 times the mass of the total water content. It contains 0.6 to 1.2 times the amount of glycerin. As mentioned above, in order to improve the usability by providing the multi-phase emulsifier type blockage and the polyhydric alcohol moisture retention (moisture retention), the content of the polyhydric alcohol is limited to the limit of the aqueous phase. It is preferable to increase. This is the value described above. By taking such a form, it is possible to add moisturizing property with a polyhydric alcohol in the multiphase emulsifier form having excellent occlusive properties without impairing the usability. The content of glycerin in the external preparation for skin is preferably 15 to 35% by mass, more preferably 17 to 25% by mass.
(4)本発明の皮膚外用剤
本発明の皮膚外用剤は、前記必須構成要件を備え、皮膚外用に投与されるべきものであることを特徴とする。本発明の皮膚外用剤に於いては、前記の成分以外に、通常皮膚外用剤で使用される任意成分を、本発明の効果を損なわない範囲に於いて、含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、;表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類;レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー、メチルシロキサン網状重合体等の有機粉体類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤、;桂皮酸系紫外線吸収剤、;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;ブチルパラベン、プロピルパラベン、エチルパラベン、メチルパラベン等のパラベン類;ウンデシレン酸モノグリセリド、フェノキシエタノール等の抗菌剤などが好ましく例示できる。
(4) External preparation for skin of the present invention The external preparation for skin of the present invention is characterized in that it has the above-mentioned essential constituents and should be administered for external use on the skin. In the external preparation for skin of the present invention, in addition to the above-mentioned components, optional components usually used in external preparations for skin can be contained within a range not impairing the effects of the present invention. Such optional ingredients include, for example, macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil Oil, wax, oil such as beeswax, canola wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum , Hydrocarbons such as microcrystalline wax; higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; cetyl alcohol, stearyl alcohol, isostearyl Higher alcohols such as alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol; cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate; dimethylpolysiloxane, methylphenylpoly Linear polysiloxanes such as oxane and diphenylpolysiloxane; cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexanesiloxane; amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Oil agents such as silicone oils such as modified polysiloxanes such as fluorine-modified polysiloxanes; Anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, triethanolamine ether of alkyl sulfates; Cationic surfactants such as stearyltrimethylammonium, benzalkonium chloride, laurylamine oxide; imidazoline-based amphoteric surfactants (2-cocoyl-2-imida Zolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), and amphoteric surfactants such as acylmethyltaurine; sorbitan fatty acid esters (sorbitan) Monostearate, sorbitan sesquioleate, etc.), glycerin fatty acids (eg, glyceryl monostearate), propylene glycol fatty acid esters (eg, propylene glycol monostearate), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid ester Tells (POE-glycerol monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl) Ethers, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), Nonionic surfactants such as sucrose fatty acid ester and alkyl glucoside; polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene Polyhydric alcohols such as recall, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol, 1,2-octanediol; sodium pyrrolidonecarboxylate Moisturizing components such as lactic acid and sodium lactate; powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, barium sulfate, etc. whose surface may be treated Body, the surface may be treated, inorganic pigments such as bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide; the surface may be treated, mica Pearl agents such as titanium, fish phosphorus foil, bismuth oxychloride; red 202 which may be raked, red Color 228, Red 226, Yellow 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201, Red 213, Yellow 204, Yellow 203, Blue 1 No., green 201, purple 201, red 204, etc .; organic powders such as polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer, methylsiloxane network polymer; paraaminobenzoic acid UV absorbers; anthranilic acid UV absorbers; salicylic acid UV absorbers; cinnamic acid UV absorbers; benzophenone UV absorbers; sugar UV absorbers; 2- (2'-hydroxy-5'- UV absorbers such as t-octylphenyl) benzotriazole, 4-methoxy-4′-t-butyldibenzoylmethane; ethanol, Lower alcohols such as isopropanol; vitamin B or its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or a derivative thereof, vitamin B such as vitamin B12, vitamin B15 or a derivative thereof; α- Vitamins such as tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin D, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone, etc .; butylparaben, propylparaben, ethylparaben, methylparaben Preferred examples include parabens such as undecylenic acid monoglyceride and phenoxyethanol.
これらの成分の内、ブチルパラベンは、最外相が油相の乳化系に於いては刺激を発現する場合が存するので含有しないことが好ましく、他のパラベン類も含有しない形がより好ましい。かかる防腐剤であるパラベン類に代えて、ウンデシレン酸モノグリセリド、フェノキシエタノールなどの抗菌成分を含有せしめ、防腐力を保持することが好ましい。これらの成分は唯1種を含有することも出来るし、2種以上を組み合わせて含有することも出来る。かかる成分の好ましい含有量は、総量で0.1〜5質量%である。特に好ましい形態は、ウンデシレン酸モノグリセリドを0.5〜4質量%とフェノキシエタノールを0.01〜1質量%とをあわせて含有する形態である。 Among these components, butylparaben is preferably not contained since there is a case where irritation is expressed in the emulsion system in which the outermost phase is an oil phase, and a form containing no other parabens is more preferred. It is preferable to retain antiseptic power by containing antibacterial components such as undecylenic acid monoglyceride and phenoxyethanol instead of parabens which are such preservatives. These components can contain only 1 type, and can also contain it in combination of 2 or more type. The preferred content of such components is 0.1 to 5% by mass in total. A particularly preferred form is a form containing 0.5 to 4% by mass of undecylenic acid monoglyceride and 0.01 to 1% by mass of phenoxyethanol.
更に、使用感を向上させる意味で球状の粉体、特にメチルシロキサン網状重合体を含有せしめることが好ましい。かかる成分の好ましい含有量は、0.1〜5質量%である。 Furthermore, it is preferable to contain a spherical powder, particularly a methylsiloxane network polymer, in order to improve the feeling of use. The preferable content of such a component is 0.1 to 5% by mass.
本発明の皮膚外用剤は、前記の必須成分、任意成分を常法に従って処理することにより、製造することが出来る。かくして得られた本発明の皮膚外用剤は、有機変性粘土鉱物を含有する乳化剤形の皮膚外用剤において、使用性と安定性に優れる。更に、優れた閉塞性と皮膚保湿性を併せ持つ。 The skin external preparation of this invention can be manufactured by processing the said essential component and arbitrary component in accordance with a conventional method. The skin external preparation of the present invention thus obtained is excellent in usability and stability in an emulsifier-type skin external preparation containing an organically modified clay mineral. Furthermore, it has excellent occlusive properties and skin moisturizing properties.
本発明の皮膚外用剤としては、皮膚に外用で適用されるものであれば特段の限定無く適用される、例えば、化粧料(医薬部外品を含む)、皮膚外用医薬、外用雑貨などが例示でき、医薬部外品を含む化粧料に適用されることが特に好ましい。これは使用性と安定性に優れ、優れた閉塞性と皮膚保湿性を併せ持つ、本発明の皮膚外用剤の特徴が生かせるからである。 The skin external preparation of the present invention is applied without particular limitation as long as it is externally applied to the skin, for example, cosmetics (including quasi-drugs), skin external medicines, and general-purpose items for external use. It is particularly preferable to be applied to cosmetics including quasi drugs. This is because the characteristics of the external preparation for skin of the present invention, which has excellent usability and stability, and has both excellent occlusive properties and skin moisturizing properties, can be utilized.
以下に、実施例を挙げて、本発明について更に詳細に説明を加えるが、本発明がかかる実施例にのみ限定されないことは言うまでもない。 Hereinafter, the present invention will be described in more detail with reference to examples, but it is needless to say that the present invention is not limited to such examples.
以下に示す処方に従って、本発明の皮膚外用剤である、化粧料1を作成した。即ち、イ、ロ、ハ、ニ、ホ、ヘの成分を80℃で加熱し、イを攪拌下徐々にロに加え、更にこれにハを加え中間乳液を作成した。ホにヘを加え、一様にし、これを攪拌下ニに加え、ゲルを生成させた。このゲルに攪拌下徐々に中間乳液を加え、攪拌冷却し、油中水中油乳化剤形の化粧料1を得た。化粧料1の「ベントン38」をモンモリロナイトに置換した比較例1、アルギン酸ナトリウムをカルボキシビニルポリマーに置換した比較例2の製造を同様の手技で試みたが、何れも乳化不能であった。化粧料1のグリセリンの内の20質量%を水に置換した比較例3を同様の手技で製造した。 According to the formulation shown below, Cosmetic 1 which is an external preparation for skin of the present invention was prepared. That is, the components of A, B, C, D, E and F were heated at 80 ° C., A was gradually added to B with stirring, and C was further added to prepare an intermediate emulsion. F was added to the mixture to make it uniform, and this was added to the mixture under stirring to form a gel. An intermediate emulsion was gradually added to the gel with stirring, and the mixture was cooled with stirring to obtain a cosmetic 1 in the form of an oil-in-water oil emulsifier. Production of Comparative Example 1 in which “Benton 38” of Cosmetic 1 was replaced with montmorillonite and Comparative Example 2 in which sodium alginate was replaced with carboxyvinyl polymer was attempted with the same procedure, but both were not emulsifiable. Comparative Example 3 in which 20% by mass of glycerin in cosmetic 1 was replaced with water was produced by the same procedure.
イ
ベヘン酸 0.4 質量%
ステアリン酸 0.15質量%
グリセリン 4.5 質量%
10%水酸化カリウム水溶液 0.45質量%
水 2.9 質量%
ロ
ベヘニルアルコール 0.5 質量%
ステアリルアルコール 0.3 質量%
スクワラン 4.5 質量%
フェノキシエタノール 0.15質量%
ハ
1,3−ブタンジオール 4.5 質量%
水 21.65
ニ
「ベントン38」 2.5 質量%
ショ糖モノステアリン酸エステル 4 質量%
スクワラン 3.5 質量%
シクロメチコン 23 質量%
ラノリン 1 質量%
ホ
グリセリン 20 質量%
メチルシロキサン網状重合体 2 質量%
フェノキシエタノール 0.15質量%
ウンデシレン酸モノグリセリド 2 質量%
ヘ
アルギン酸ナトリウム(高純度品) 0.2 質量%
水 1.65質量%
*水の量:26.2質量%、グリセリンの量:24.5質量%
Ibehenic acid 0.4% by mass
Stearic acid 0.15% by mass
Glycerin 4.5% by mass
10% aqueous potassium hydroxide 0.45 mass%
Water 2.9% by mass
Robehenyl alcohol 0.5 mass%
Stearyl alcohol 0.3% by mass
Squalane 4.5 mass%
Phenoxyethanol 0.15% by mass
1,3-butanediol 4.5% by mass
Water 21.65
D "Benton 38" 2.5 mass%
Sucrose monostearate 4% by mass
Squalane 3.5 wt%
Cyclomethicone 23% by mass
Lanolin 1% by mass
Hoglycerin 20% by mass
Methylsiloxane network polymer 2% by mass
Phenoxyethanol 0.15% by mass
Undecylenic acid monoglyceride 2% by mass
Sodium helginate (high purity product) 0.2% by mass
1.65% by weight of water
* Amount of water: 26.2% by mass, amount of glycerin: 24.5% by mass
<試験例1>
化粧料1と比較例1とを用いて、パネラーの上腕内側部の2cm×4cmの部位を処理し(サンプルの使用量:各20mg)、その20分後に「スキコン200」(イー・ビー社製)を用いて皮膚水分量を計測した。結果を表1に示す。これより、本発明の皮膚外用剤では閉塞効果とグリセリンによる保湿効果により、皮膚水分量が著しく増大していることが判る。
<Test Example 1>
Using the cosmetic 1 and the comparative example 1, a 2 cm × 4 cm portion of the inner arm of the panel was processed (amount of sample used: 20 mg each), and after 20 minutes, “Skikon 200” (manufactured by EB Corp.) ) Was used to measure skin moisture. The results are shown in Table 1. From this, it can be seen that in the external preparation for skin of the present invention, the moisture content of the skin is remarkably increased by the occlusion effect and the moisturizing effect by glycerin.
実施例1と同様に、下記の処方に従って本発明の皮膚外用剤である化粧料2を作成した。皮膚水分量についても同様に測定したところ、化粧料2の処置部位は58であり、無処置部位は36であった。同様の効果が存することが判る。 In the same manner as in Example 1, cosmetic 2 as an external preparation for skin of the present invention was prepared according to the following formulation. The skin moisture content was also measured in the same manner. As a result, the treatment site of Cosmetic 2 was 58 and the non-treatment site was 36. It can be seen that a similar effect exists.
イ
ベヘン酸 0.4 質量%
ステアリン酸 0.15質量%
グリセリン 4.5 質量%
10%水酸化カリウム水溶液 0.45質量%
水 2.9 質量%
ロ
ベヘニルアルコール 0.5 質量%
ステアリルアルコール 0.3 質量%
スクワラン 4.5 質量%
フェノキシエタノール 0.15質量%
ハ
1,3−ブタンジオール 4.5 質量%
水 21.65
ニ
「ベントン38」 2.5 質量%
ショ糖モノステアリン酸エステル 4 質量%
スクワラン 3.5 質量%
シクロメチコン 23 質量%
ラノリン 1 質量%
ホ
グリセリン 20 質量%
メチルシロキサン網状重合体 2 質量%
フェノキシエタノール 0.15質量%
ウンデシレン酸モノグリセリド 2 質量%
ヘ
アルギン酸ナトリウム(超低粘度品) 0.2 質量%
水 1.65質量%
*水の量:26.2質量%、グリセリンの量:24.5質量%
Ibehenic acid 0.4% by mass
Stearic acid 0.15% by mass
Glycerin 4.5% by mass
10% aqueous potassium hydroxide 0.45 mass%
Water 2.9% by mass
Robehenyl alcohol 0.5 mass%
Stearyl alcohol 0.3% by mass
Squalane 4.5 mass%
Phenoxyethanol 0.15% by mass
1,3-butanediol 4.5% by mass
Water 21.65
D "Benton 38" 2.5 mass%
Sucrose monostearate 4% by mass
Squalane 3.5 wt%
Cyclomethicone 23% by mass
Lanolin 1% by mass
Hoglycerin 20% by mass
Methylsiloxane network polymer 2% by mass
Phenoxyethanol 0.15% by mass
Undecylenic acid monoglyceride 2% by mass
Sodium helginate (ultra-low viscosity product) 0.2% by mass
1.65% by weight of water
* Amount of water: 26.2% by mass, amount of glycerin: 24.5% by mass
実施例1と同様に、下記の処方に従って本発明の皮膚外用剤である化粧料3を作成した。皮膚水分量についても同様に測定したところ、化粧料3の処置部位は51であり、無処置部位は31であった。同様の効果が存することが判る。グリセリン量は水分の含有量に対して、0.5〜1.5倍質量が好ましく、より好ましくは、0.6〜1.2倍量であることが判る。 In the same manner as in Example 1, cosmetic 3 as an external preparation for skin of the present invention was prepared according to the following formulation. The skin moisture content was also measured in the same manner. As a result, the treatment site of Cosmetic 3 was 51 and the non-treatment site was 31. It can be seen that a similar effect exists. It can be seen that the amount of glycerin is preferably 0.5 to 1.5 times the mass of the water content, and more preferably 0.6 to 1.2 times.
イ
ベヘン酸 0.4 質量%
ステアリン酸 0.15質量%
グリセリン 4.5 質量%
10%水酸化カリウム水溶液 0.45質量%
水 2.9 質量%
ロ
ベヘニルアルコール 0.5 質量%
ステアリルアルコール 0.3 質量%
スクワラン 4.5 質量%
フェノキシエタノール 0.15質量%
ハ
1,3−ブタンジオール 4.5 質量%
水 21.65
ニ
「ベントン38」 2.5 質量%
ショ糖モノステアリン酸エステル 4 質量%
スクワラン 3.5 質量%
シクロメチコン 23 質量%
ラノリン 1 質量%
ホ
グリセリン 15 質量%
メチルシロキサン網状重合体 2 質量%
フェノキシエタノール 0.15質量%
ウンデシレン酸モノグリセリド 2 質量%
ヘ
アルギン酸ナトリウム(高純度品) 0.2 質量%
水 6.65質量%
*水の量:31.2質量%、グリセリンの量:19.5質量%
Ibehenic acid 0.4% by mass
Stearic acid 0.15% by mass
Glycerin 4.5% by mass
10% aqueous potassium hydroxide 0.45 mass%
Water 2.9% by mass
Robehenyl alcohol 0.5 mass%
Stearyl alcohol 0.3% by mass
Squalane 4.5 mass%
Phenoxyethanol 0.15% by mass
1,3-butanediol 4.5% by mass
Water 21.65
D "Benton 38" 2.5 mass%
Sucrose monostearate 4% by mass
Squalane 3.5 wt%
Cyclomethicone 23% by mass
Lanolin 1% by mass
Hoglycerin 15% by mass
Methylsiloxane network polymer 2% by mass
Phenoxyethanol 0.15% by mass
Undecylenic acid monoglyceride 2% by mass
Sodium helginate (high purity product) 0.2% by mass
6.65% by mass of water
* Amount of water: 31.2% by mass, amount of glycerin: 19.5% by mass
<参考例1>
モンモリロナイト100gを水1lに分散させ、これに500mlの水に20gのステアリルトリメチルアンモニウムクロリドを溶かしたものを加え、凍結乾燥させ、有機変性モンモリロナイト1を得た。
<Reference Example 1>
100 g of montmorillonite was dispersed in 1 l of water, 20 g of stearyltrimethylammonium chloride dissolved in 500 ml of water was added thereto, and lyophilized to obtain organically modified montmorillonite 1.
実施例1と同様に、下記の処方に従って本発明の皮膚外用剤である化粧料4を作成した。皮膚水分量についても同様に測定したところ、化粧料4の処置部位は53であり、無処置部位は38であった。同様の効果が存することが判る。 In the same manner as in Example 1, cosmetic 4 as an external preparation for skin of the present invention was prepared according to the following formulation. The skin moisture content was also measured in the same manner. As a result, the treatment site of cosmetic 4 was 53 and the non-treatment site was 38. It can be seen that a similar effect exists.
イ
ベヘン酸 0.4 質量%
ステアリン酸 0.15質量%
グリセリン 4.5 質量%
10%水酸化カリウム水溶液 0.45質量%
水 2.9 質量%
ロ
ベヘニルアルコール 0.5 質量%
ステアリルアルコール 0.3 質量%
スクワラン 4.5 質量%
フェノキシエタノール 0.15質量%
ハ
1,3−ブタンジオール 4.5 質量%
水 21.65
ニ
有機変性モンモリロナイト1 2.5 質量%
ショ糖モノステアリン酸エステル 4 質量%
スクワラン 3.5 質量%
シクロメチコン 23 質量%
ラノリン 1 質量%
ホ
グリセリン 20 質量%
メチルシロキサン網状重合体 2 質量%
フェノキシエタノール 0.15質量%
ウンデシレン酸モノグリセリド 2 質量%
ヘ
アルギン酸ナトリウム(高純度品) 0.2 質量%
水 1.65質量%
*水の量:26.2質量%、グリセリンの量:24.5質量%
Ibehenic acid 0.4% by mass
Stearic acid 0.15% by mass
Glycerin 4.5% by mass
10% aqueous potassium hydroxide 0.45 mass%
Water 2.9% by mass
Robehenyl alcohol 0.5 mass%
Stearyl alcohol 0.3% by mass
Squalane 4.5 mass%
Phenoxyethanol 0.15% by mass
1,3-butanediol 4.5% by mass
Water 21.65
Organically modified montmorillonite 1 2.5% by mass
Sucrose monostearate 4% by mass
Squalane 3.5 wt%
Cyclomethicone 23% by mass
Lanolin 1% by mass
Hoglycerin 20% by mass
Methylsiloxane network polymer 2% by mass
Phenoxyethanol 0.15% by mass
Undecylenic acid monoglyceride 2% by mass
Sodium helginate (high purity product) 0.2% by mass
1.65% by weight of water
* Amount of water: 26.2% by mass, amount of glycerin: 24.5% by mass
<参考例2>
サポナイト100gを水1lに分散させ、これに500mlの水に20gのジメチルジステアリルアンモニウムクロリドを溶かしたものを加え、凍結乾燥させ、有機変性サポナイト1を得た。
<Reference Example 2>
100 g of saponite was dispersed in 1 liter of water, and 20 g of dimethyl distearyl ammonium chloride dissolved in 500 ml of water was added thereto and freeze-dried to obtain organically modified saponite 1.
実施例1と同様に、下記の処方に従って本発明の皮膚外用剤である化粧料5を作成した。皮膚水分量についても同様に測定したところ、化粧料5の処置部位は59であり、無処置部位は41であった。同様の効果が存することが判る。 In the same manner as in Example 1, cosmetic 5 as an external preparation for skin of the present invention was prepared according to the following formulation. The skin moisture content was also measured in the same manner. As a result, the treatment site of cosmetic 5 was 59 and the non-treatment site was 41. It can be seen that a similar effect exists.
イ
ベヘン酸 0.4 質量%
ステアリン酸 0.15質量%
グリセリン 4.5 質量%
10%水酸化カリウム水溶液 0.45質量%
水 2.9 質量%
ロ
ベヘニルアルコール 0.5 質量%
ステアリルアルコール 0.3 質量%
スクワラン 4.5 質量%
フェノキシエタノール 0.15質量%
ハ
1,3−ブタンジオール 4.5 質量%
水 21.65
ニ
有機変性サポナイト1 2.5 質量%
ショ糖モノステアリン酸エステル 4 質量%
スクワラン 3.5 質量%
シクロメチコン 23 質量%
ラノリン 1 質量%
ホ
グリセリン 20 質量%
メチルシロキサン網状重合体 2 質量%
フェノキシエタノール 0.15質量%
ウンデシレン酸モノグリセリド 2 質量%
ヘ
アルギン酸ナトリウム(高純度品) 0.2 質量%
水 1.65質量%
*水の量:26.2質量%、グリセリンの量:24.5質量%
Ibehenic acid 0.4% by mass
Stearic acid 0.15% by mass
Glycerin 4.5% by mass
10% aqueous potassium hydroxide 0.45 mass%
Water 2.9% by mass
Robehenyl alcohol 0.5 mass%
Stearyl alcohol 0.3% by mass
Squalane 4.5 mass%
Phenoxyethanol 0.15% by mass
1,3-butanediol 4.5% by mass
Water 21.65
Organically modified saponite 1 2.5% by mass
Sucrose monostearate 4% by mass
Squalane 3.5 wt%
Cyclomethicone 23% by mass
Lanolin 1% by mass
Hoglycerin 20% by mass
Methylsiloxane network polymer 2% by mass
Phenoxyethanol 0.15% by mass
Undecylenic acid monoglyceride 2% by mass
Sodium helginate (high purity product) 0.2% by mass
1.65% by weight of water
* Amount of water: 26.2% by mass, amount of glycerin: 24.5% by mass
<参考例3>
ヘクトライト100gを水1lに分散させ、これに500mlの水に20gのジメチルジステアリルアンモニウムクロリドを溶かしたものを加え、凍結乾燥させ、有機変性ヘクトライト1を得た。
<Reference Example 3>
100 g of hectorite was dispersed in 1 l of water, 20 g of dimethyl distearyl ammonium chloride dissolved in 500 ml of water was added thereto, and lyophilized to obtain organically modified hectorite 1.
実施例1と同様に、下記の処方に従って本発明の皮膚外用剤である化粧料6を作成した。皮膚水分量についても同様に測定したところ、化粧料6の処置部位は55であり、無処置部位は38であった。同様の効果が存することが判る。 In the same manner as in Example 1, cosmetic 6 as a skin external preparation of the present invention was prepared according to the following formulation. The skin moisture content was also measured in the same manner. As a result, the treatment site of cosmetic 6 was 55 and the non-treatment site was 38. It can be seen that a similar effect exists.
イ
ベヘン酸 0.4 質量%
ステアリン酸 0.15質量%
グリセリン 4.5 質量%
10%水酸化カリウム水溶液 0.45質量%
水 2.9 質量%
ロ
ベヘニルアルコール 0.5 質量%
ステアリルアルコール 0.3 質量%
スクワラン 4.5 質量%
フェノキシエタノール 0.15質量%
ハ
1,3−ブタンジオール 4.5 質量%
水 21.65
ニ
有機変性ヘクトライト1 2.5 質量%
ショ糖モノステアリン酸エステル 4 質量%
スクワラン 3.5 質量%
シクロメチコン 23 質量%
ラノリン 1 質量%
ホ
グリセリン 20 質量%
メチルシロキサン網状重合体 2 質量%
フェノキシエタノール 0.15質量%
ウンデシレン酸モノグリセリド 2 質量%
ヘ
アルギン酸ナトリウム(高純度品) 0.2 質量%
水 1.65質量%
*水の量:26.2質量%、グリセリンの量:24.5質量%
Ibehenic acid 0.4% by mass
Stearic acid 0.15% by mass
Glycerin 4.5% by mass
10% aqueous potassium hydroxide 0.45 mass%
Water 2.9% by mass
Robehenyl alcohol 0.5 mass%
Stearyl alcohol 0.3% by mass
Squalane 4.5 mass%
Phenoxyethanol 0.15% by mass
1,3-butanediol 4.5% by mass
Water 21.65
Organically modified hectorite 1 2.5% by mass
Sucrose monostearate 4% by mass
Squalane 3.5 wt%
Cyclomethicone 23% by mass
Lanolin 1% by mass
Hoglycerin 20% by mass
Methylsiloxane network polymer 2% by mass
Phenoxyethanol 0.15% by mass
Undecylenic acid monoglyceride 2% by mass
Sodium helginate (high purity product) 0.2% by mass
1.65% by weight of water
* Amount of water: 26.2% by mass, amount of glycerin: 24.5% by mass
本発明は、化粧料に応用できる。 The present invention can be applied to cosmetics.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005144068A JP2006321725A (en) | 2005-05-17 | 2005-05-17 | Emulsion-form skin preparation for external use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005144068A JP2006321725A (en) | 2005-05-17 | 2005-05-17 | Emulsion-form skin preparation for external use |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006321725A true JP2006321725A (en) | 2006-11-30 |
JP2006321725A5 JP2006321725A5 (en) | 2008-05-01 |
Family
ID=37541656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005144068A Pending JP2006321725A (en) | 2005-05-17 | 2005-05-17 | Emulsion-form skin preparation for external use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006321725A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007308384A (en) * | 2006-05-16 | 2007-11-29 | Pola Chem Ind Inc | Emulsion type external preparation for skin |
JP2007308385A (en) * | 2006-05-16 | 2007-11-29 | Pola Chem Ind Inc | Emulsion type external preparation for skin |
JP2007308381A (en) * | 2006-05-16 | 2007-11-29 | Pola Chem Ind Inc | External preparation for skin in water-in-oil type emulsion form |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62216635A (en) * | 1986-03-18 | 1987-09-24 | Shiseido Co Ltd | Water-in-oil and polyhydric alcohol type emulsion composition |
JPH01287008A (en) * | 1988-02-16 | 1989-11-17 | Richardson Vicks Inc | Skin conditioning composition |
JPH09255562A (en) * | 1996-03-28 | 1997-09-30 | Shiseido Co Ltd | Composite emulsion and its production |
JPH1129459A (en) * | 1997-07-04 | 1999-02-02 | Shiseido Co Ltd | Water-in-oil type emulsified composition |
JP2001206816A (en) * | 1999-11-19 | 2001-07-31 | Frontier:Kk | Milky lotion having skin-softening property and antimicrobial activity, cosmetic preparation and skin- cleansing article |
-
2005
- 2005-05-17 JP JP2005144068A patent/JP2006321725A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62216635A (en) * | 1986-03-18 | 1987-09-24 | Shiseido Co Ltd | Water-in-oil and polyhydric alcohol type emulsion composition |
JPH01287008A (en) * | 1988-02-16 | 1989-11-17 | Richardson Vicks Inc | Skin conditioning composition |
JPH09255562A (en) * | 1996-03-28 | 1997-09-30 | Shiseido Co Ltd | Composite emulsion and its production |
JPH1129459A (en) * | 1997-07-04 | 1999-02-02 | Shiseido Co Ltd | Water-in-oil type emulsified composition |
JP2001206816A (en) * | 1999-11-19 | 2001-07-31 | Frontier:Kk | Milky lotion having skin-softening property and antimicrobial activity, cosmetic preparation and skin- cleansing article |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007308384A (en) * | 2006-05-16 | 2007-11-29 | Pola Chem Ind Inc | Emulsion type external preparation for skin |
JP2007308385A (en) * | 2006-05-16 | 2007-11-29 | Pola Chem Ind Inc | Emulsion type external preparation for skin |
JP2007308381A (en) * | 2006-05-16 | 2007-11-29 | Pola Chem Ind Inc | External preparation for skin in water-in-oil type emulsion form |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5930817B2 (en) | Skin external composition | |
JP2009084232A (en) | Emulsifier-type powder-containing external preparation for skin | |
JP2008019230A5 (en) | ||
JP5827079B2 (en) | Powder-containing skin external preparation | |
JP6180816B2 (en) | Topical skin preparation | |
JP2009149554A (en) | Skin preparation for external use, having oil-in-water emulsion form | |
JP2009040738A (en) | Water-in-oil emulsifier type external preparation for skin | |
JP2008031141A (en) | Skin external preparation in the form of water-in-oil emulsifier | |
JP2008297239A (en) | Water-in-oil type external preparation for skin | |
JP5259973B2 (en) | Emulsifier type skin external preparation | |
JP6180817B2 (en) | Topical skin preparation | |
JP2006321725A (en) | Emulsion-form skin preparation for external use | |
JP2008120757A5 (en) | ||
JP5653401B2 (en) | Method for producing powder-containing external preparation for skin containing emulsifier | |
JP2010030933A (en) | Skin care preparation for external use | |
JP2009155241A (en) | Multi-layer treated powder-containing aqueous skin preparation | |
JP2005154318A (en) | Skin care preparation for external use containing carboxyvinyl polymer | |
JP2006298868A (en) | External preparation for skin, suitable for cleansing cosmetic | |
JP4676730B2 (en) | Emulsifier type skin external preparation | |
JP2009149555A (en) | Skin preparation for external use, having oil-in-water emulsion form | |
JP5635223B2 (en) | Skin external preparation suitable for esthetic treatment | |
JP2008222651A (en) | External preparation for skin in emulsifier form | |
JP2008137955A (en) | Emulsified composition and method for producing the same, and cosmetic using the same | |
JP4801361B2 (en) | Essence dosage form topical skin preparation | |
JP2006076899A (en) | Emulsion-type skin care preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Effective date: 20080228 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080228 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20080228 |
|
A977 | Report on retrieval |
Effective date: 20100616 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100622 |
|
A02 | Decision of refusal |
Effective date: 20101019 Free format text: JAPANESE INTERMEDIATE CODE: A02 |